Core Insights - The event "Italy on the Move" aims to promote investment opportunities in Italy's life sciences sector, which is valued at €270 billion, representing 11% of the country's GDP [1][3] - The Italian life sciences ecosystem is highlighted as a competitive hub for investments in biotech, healthcare, medical devices, and pharmaceuticals, attracting nearly 50 multinational companies [3] - The event will feature discussions on transatlantic partnerships and showcase innovative Italian startups, providing a platform for U.S. healthcare companies and investors to connect with Italian firms [3][4] Investment Opportunities - Italy's life sciences sector is recognized as a significant contributor to the economy, with pharmaceuticals and medical devices being the third largest export category [3] - The event will facilitate partnerships between U.S. and Italian companies, emphasizing Italy's leading position in the EU for pharma CDMO manufacturing value and its global ranking in patents productivity [3][4] - The eighth edition of "Italy on the Move" will include pitch presentations from five key Italian startups, enhancing visibility for innovative SMEs [4] Event Details - The event will take place on January 15, 2025, at INNOVIT in San Francisco, coinciding with the J.P. Morgan Healthcare Conference [1][3] - Keynote speeches will be delivered by prominent figures, including the Ambassador of Italy to the U.S. and the Director General for the Promotion of the Italy System [2][3] - A panel discussion titled "Navigating Transatlantic Partnerships in Life Sciences" will be moderated by a notable industry leader, providing insights into collaboration opportunities [3]
ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE